Magnus Nylén

Director/Board Member at SELECTIMMUNE PHARMA AB (PUBL)

Health Technology

Consumer Services

Finance

Profile

Magnus Nylén is currently Director at Hamlet BioPharma AB starting in 2025.
Mr. Nylén is also Director at SelectImmune Pharma AB since 2022.
Additionally, Mr. Nylén has been Owner at Partner Fondkommission AB since 2013.
Mr. Nylén completed undergraduate education at Boston University.

Magnus Nylén active positions

Companies	Position	Start
SELECTIMMUNE PHARMA AB (PUBL)	Director/Board Member	22/11/2022
HAMLET PHARMA AB (PUBL)	Director/Board Member	10/03/2025
Partner Fondkommission AB Partner Fondkommission AB Investment ManagersFinance Offers financial advisory	Corporate Officer/Principal	31/12/2012

All active positions of Magnus Nylén

Training of Magnus Nylén

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Magnus Nylén's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Partner Fondkommission AB Partner Fondkommission AB Investment ManagersFinance Offers financial advisory	Finance
Hamlet BioPharma AB Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients	Health Technology
SelectImmune Pharma AB SelectImmune Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and manufactures immune enhancers to complement antibiotics	Health Technology